Shanghai Fudan Forward S&T Co., Ltd (SHA:600624)

Market Cap	4.83B
Revenue (ttm)	652.36M
Net Income (ttm)	-124.56M
Shares Out	679.35M
EPS (ttm)	-0.18
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,924,449
Average Volume	20,791,390
Open	6.89
Previous Close	6.92
Day's Range	6.87 - 7.32
52-Week Range	3.09 - 9.50
Beta	0.44
RSI	49.15
Earnings Date	Aug 30, 2025

About SHA:600624

Shanghai Fudan Forward S&T Co., Ltd operates in software development, biomedicine, real estate, and other businesses. The company develops and exports software to Japan; and researches, develops, produces, and sells chemical drugs, Chinese patent medicines, freeze-dried powder injections, and solid preparations, as well as chemical raw materials, digestive system drugs, nervous system drugs, antineoplastic drugs, circulatory system drugs, and traditional and modern Chinese medicines. It is also involved in the development of high-tech parks; an...

• Industry: Conglomerates
• Sector: Industrials
• Founded: 1984
• Employees: 1,414
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600624

Financial Performance

In 2024, SHA:600624's revenue was 645.32 million, a decrease of -5.05% compared to the previous year's 679.68 million. Losses were -133.21 million, 509.4% more than in 2023.